Financials Bachem Holding AG

Equities

BANB

CH1176493729

Biotechnology & Medical Research

Real-time Estimate Cboe Europe 08:33:00 2024-04-30 am EDT 5-day change 1st Jan Change
79.48 CHF -2.12% Intraday chart for Bachem Holding AG -1.73% +22.69%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 2,165 5,534 10,558 5,889 4,873 6,088 - -
Enterprise Value (EV) 1 2,251 5,618 10,490 5,858 4,575 6,023 6,163 6,391
P/E ratio 7.92 x 14.2 x 17.7 x 58.3 x 43.3 x 50.7 x 38.4 x 32.6 x
Yield 9.69% 4.11% 2.44% 0.94% 1.23% 1.06% 1.15% 1.38%
Capitalization / Revenue 6.9 x 13.8 x 21 x 11.1 x 8.44 x 9.82 x 7.51 x 6.04 x
EV / Revenue 7.17 x 14 x 20.8 x 11 x 7.92 x 9.72 x 7.6 x 6.34 x
EV / EBITDA 25.8 x 45.8 x 66.6 x 36.5 x 27.4 x 33.3 x 25.5 x 20.6 x
EV / FCF 66.8 x 122 x -544 x -128 x -311 x 361 x -41.1 x -39.4 x
FCF Yield 1.5% 0.82% -0.18% -0.78% -0.32% 0.28% -2.43% -2.54%
Price to Book 0.96 x 2.33 x 1.81 x 5.03 x 3.68 x 4.51 x 4.24 x 3.89 x
Nbr of stocks (in thousands) 69,926 69,959 73,732 73,750 74,971 74,974 - -
Reference price 2 30.96 79.10 143.2 79.85 65.00 81.20 81.20 81.20
Announcement Date 3/13/20 3/12/21 3/18/22 3/7/23 2/26/24 - - -
1CHF in Million2CHF
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 313.7 402 503.2 531.7 577.3 619.9 811 1,008
EBITDA 1 87.2 122.6 157.4 160.5 166.7 180.7 241.7 309.7
EBIT 1 62.36 96.7 128.9 127.2 129.4 140.9 176.9 234
Operating Margin 19.88% 24.05% 25.62% 23.93% 22.41% 22.72% 21.81% 23.22%
Earnings before Tax (EBT) 1 60.37 90.96 131.4 112.1 124.2 147.9 185.7 200.8
Net income 1 54.16 78.1 114.7 100.7 111.9 127.4 160.1 170.7
Net margin 17.27% 19.43% 22.79% 18.93% 19.38% 20.56% 19.74% 16.94%
EPS 2 3.910 5.580 8.090 1.370 1.500 1.602 2.114 2.487
Free Cash Flow 1 33.68 45.94 -19.27 -45.81 -14.7 16.7 -150 -162.1
FCF margin 10.74% 11.43% -3.83% -8.62% -2.55% 2.69% -18.49% -16.08%
FCF Conversion (EBITDA) 38.62% 37.47% - - - 9.24% - -
FCF Conversion (Net income) 62.18% 58.83% - - - 13.1% - -
Dividend per Share 2 3.000 3.250 3.500 0.7500 0.8000 0.8600 0.9333 1.117
Announcement Date 3/13/20 3/12/21 3/18/22 3/7/23 2/26/24 - - -
1CHF in Million2CHF
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2019 S2 2020 S1 2020 S2 2021 S1 2021 S2 2022 S1 2022 S2 2023 S1
Net sales 1 179.2 177.1 224.9 239.1 264.1 234.9 296.9 239.9
EBITDA 1 50.7 53 69.6 75.5 81.9 67.3 93.2 52.5
EBIT 1 37.94 40.26 56.44 61.95 66.95 51.56 75.66 34.82
Operating Margin 21.17% 22.73% 25.1% 25.9% 25.35% 21.95% 25.49% 14.51%
Earnings before Tax (EBT) 1 - - - - - 40.36 71.72 36.92
Net income 1 - 32.83 45.27 53.12 61.58 36.61 64.07 34.45
Net margin - 18.53% 20.13% 22.21% 23.32% 15.59% 21.58% 14.36%
EPS 2 - 2.350 3.230 3.800 4.290 0.5000 0.8700 0.4600
Dividend per Share - - - - - - - -
Announcement Date 3/13/20 8/21/20 3/12/21 8/27/21 3/18/22 8/25/22 3/7/23 7/27/23
1CHF in Million2CHF
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 85.7 84.1 - - - - 74.8 303
Net Cash position 1 - - 68.3 30.8 299 64.9 - -
Leverage (Debt/EBITDA) 0.9825 x 0.6856 x - - - - 0.3096 x 0.9789 x
Free Cash Flow 1 33.7 45.9 -19.3 -45.8 -14.7 16.7 -150 -162
ROE (net income / shareholders' equity) 13% 16.9% 14.4% 8.8% 9% 9.54% 10.8% 12.9%
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2 32.40 34.00 79.10 15.90 17.70 18.00 19.20 20.90
Cash Flow per Share 2 4.640 8.220 6.890 1.260 3.350 1.860 2.230 3.040
Capex 1 28.8 65.5 115 138 265 308 261 285
Capex / Sales 9.18% 16.3% 22.77% 26.04% 45.83% 49.71% 32.2% 28.31%
Announcement Date 3/13/20 3/12/21 3/18/22 3/7/23 2/26/24 - - -
1CHF in Million2CHF
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
6
Last Close Price
81.2 CHF
Average target price
70.8 CHF
Spread / Average Target
-12.81%
Consensus
  1. Stock Market
  2. Equities
  3. BANB Stock
  4. Financials Bachem Holding AG